English
Back
Download
Log in to access Online Inquiry
Back to the Top

NEWS

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million


Tiziana Life Sciences announced a registered direct offering of 5,263,158 common shares at $0.95 per share, raising approximately $5 million in gross proceeds. The company also issued an option for investors to acquire an additional 5,263,158 shares at the same price within 75 days, potentially raising another $5 million. The proceeds will fund Phase 2a clinical trials for intranasal foralumab in multiple sclerosis patients, accelerate Alzheimer's disease research, develop foralumab for other indications, and support working capital needs. The offering is expected to close around November 1, 2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
4291 Views
Comment
Sign in to post a comment
    Spread kindness and love. Life is short. Don’t let greed eat you.
    6057Followers
    70Following
    65KVisitors
    Follow
    Discussing
    Trump 2.0 countdown: What's the next big opportunity in the markets?
    Trump is gearing up for a return to the political stage, and his "America First" tariff policies, along with his stance on cryptocurrency an Show More